Role of neonatal community outreach team in weaning of home oxygen therapy in preterm infants with bronchopulmonary dysplasia in community

2021 ◽  
Author(s):  
C. Bhatia ◽  
D. Jubilo ◽  
J. Wurie ◽  
J. Kefas
Keyword(s):  
Preterm Infants ◽  
Bronchopulmonary Dysplasia ◽  
Oxygen Therapy ◽  
Community Outreach ◽  
Home Oxygen Therapy ◽  
Outreach Team

Hyaline Membrane Disease Treated with Bovine Surfactant

PEDIATRICS ◽  
1983 ◽  
Vol 71 (6) ◽  
pp. 913-917
Author(s):  
J. A. Smyth ◽  
I. L. Metcalfe ◽  
P. Duffty ◽  
F. Possmayer ◽  
M. H. Bryan ◽  
...  
Keyword(s):  
Preterm Infants ◽  
Bronchopulmonary Dysplasia ◽  
Oxygen Therapy ◽  
Hyaline Membrane Disease ◽  
Variable Degree ◽  
Arterial Oxygenation ◽  
Hyaline Membrane

Six preterm infants with severe hyaline membrane disease requiring ventilation were treated, at a median age of 15.5 hours, with a single intratracheal bolus of a bovine surfactant suspension. Arterial oxygenation increased dramatically, and chest radiograms showed improvement after two to four hours. However, a variable degree of deterioration occurred within 24 hours. All of the infants required oxygen therapy for several weeks, and one developed severe bronchopulmonary dysplasia.

scholarly journals Targeting Bronchopulmonary Dysplasia-Associated Pulmonary Hypertension (BPD-PH): Potential Role of the FGF Signaling Pathway in the Development of the Pulmonary Vascular System

Cells ◽  
2020 ◽  
Vol 9 (8) ◽  
pp. 1875
Author(s):  
Cho-Ming Chao ◽  
Lei Chong ◽  
Xuran Chu ◽  
Amit Shrestha ◽  
Judith Behnke ◽  
...  
Keyword(s):  
Pulmonary Hypertension ◽  
Signaling Pathway ◽  
Preterm Infants ◽  
Bronchopulmonary Dysplasia ◽  
Potential Role ◽  
Vascular System ◽  
Point Of View ◽  
Pulmonary Vasculature ◽  
Curative Therapy

More than 50 years after the first description of Bronchopulmonary dysplasia (BPD) by Northway, this chronic lung disease affecting many preterm infants is still poorly understood. Additonally, approximately 40% of preterm infants suffering from severe BPD also suffer from Bronchopulmonary dysplasia-associated pulmonary hypertension (BPD-PH), leading to a significant increase in total morbidity and mortality. Until today, there is no curative therapy for both BPD and BPD-PH available. It has become increasingly evident that growth factors are playing a central role in normal and pathologic development of the pulmonary vasculature. Thus, this review aims to summarize the recent evidence in our understanding of BPD-PH from a basic scientific point of view, focusing on the potential role of Fibroblast Growth Factor (FGF)/FGF10 signaling pathway contributing to disease development, progression and resolution.

The impact of oxygen therapy in preterm infants with bronchopulmonary dysplasia

2017 ◽  
Author(s):  
Cristina Tomacinschii ◽  
Aliona Cotoman ◽  
Svetlana Sciuca ◽  
Rodica Selevestru ◽  
Olesea Aioani
Keyword(s):  
Preterm Infants ◽  
Bronchopulmonary Dysplasia ◽  
Oxygen Therapy ◽  
The Impact

Duration of home oxygen therapy and postnatal catch-up growth in bronchopulmonary dysplasia

2020 ◽  
Author(s):  
Manisha Ramphul ◽  
Anna Poghosyan ◽  
Dushyant Batra ◽  
Andrew Prayle ◽  
Jayesh M Bhatt
Keyword(s):  
Bronchopulmonary Dysplasia ◽  
Oxygen Therapy ◽  
Home Oxygen Therapy ◽  
Catch Up
Sign in / Sign up

Export Citation Format

Share Document